New Fixed-Dose Combinations of Fenofibrate/Simvastatin Therapy Significantly Improve the Lipid Profile of High-Risk Patients with Mixed Dyslipidemia Versus Monotherapies.
about
New Fixed-Dose Combinations of Fenofibrate/Simvastatin Therapy Significantly Improve the Lipid Profile of High-Risk Patients with Mixed Dyslipidemia Versus Monotherapies.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
New Fixed-Dose Combinations of ...... ipidemia Versus Monotherapies.
@en
New Fixed-Dose Combinations of ...... ipidemia Versus Monotherapies.
@nl
type
label
New Fixed-Dose Combinations of ...... ipidemia Versus Monotherapies.
@en
New Fixed-Dose Combinations of ...... ipidemia Versus Monotherapies.
@nl
prefLabel
New Fixed-Dose Combinations of ...... ipidemia Versus Monotherapies.
@en
New Fixed-Dose Combinations of ...... ipidemia Versus Monotherapies.
@nl
P2093
P2860
P356
P1476
New Fixed-Dose Combinations of ...... ipidemia Versus Monotherapies.
@en
P2093
Anna Lochocka
Axel Schaeffer
Cesar Gonzalo Calvo Vargas
Cholib study Investigators
Christelle Foucher
Dmitry Belenky
Hans-Friedrich Koch
Mario Berli
Patrick Aubonnet
Petr Reichert
P2860
P304
P356
10.1111/1755-5922.12148
P577
2015-12-01T00:00:00Z